Phacilitate Leaders World

Conference speakers

Loading
Lisa Mostovoy

Lisa Mostovoy

Executive Director, Clinical Value, Office of Clinical Affairs, Blue Cross Blue Shield

Lisa Mostovoy, PharmD, MBA is the Executive Director of Clinical Value with the Office of Clinical Affairs at Blue Cross Blue Shield Association (BCBSA). As the Executive Director of Clinical Value, Lisa is responsible for clinical pharmacy leadership across multiple responsibilities including: clinical pharmacy input, pharmacy reporting, P&T committee involvement, and value based contracting. Prior to joining the Office of Clinical Affairs, Lisa led the Pharmacy Programs team for Blue Cross Blue Shield Federal Employee Plan (BCBSA FEP). Prior to joining BCBSA, she managed national employer groups at CVS Health focusing on overall clinical strategy, clinical program innovation, management of complex custom formularies, utilization management, and benefit design. Lisa completed a managed care residency with CVS Health. During her professional career and residency, Lisa precepted pharmacy residents and taught a managed care course at Midwestern University in Glendale, AZ. Lisa holds a Bachelor of Biology from Villa Julie College, Doctor of Pharmacy from University of Maryland, and Masters of Business Administration from University of Baltimore.

Sessions
Testimonials
  • Real thinking forward combining experts in the field from manufacturing, regulatory and value vision” – “great network with strong experience and sharing risks & opportunities
    Anne-Virginie Eggimann
    bluebird bio
  • Great program, great people, great venue.
    Klaus Kühlcke
    EUFETS GmbH
  • Dynamic, interesting and highly interactive event that promotes exchange and networking in highly specialized field of gene therapy.
    Nathalie Clement
    Powell Gene Therapy Center, University of Florida
  • Phacilitate provides a unique forum, bringing together research, process development, and commercial leaders on the cutting edge of cell, gene, and immunotherapy. A great conference for anyone wanting a comprehensive view of the field.
    Dr James Trager
    Dendreon
  • It was all business. I’ve never been to an event where over 80% of the conversations I had were constructive to my business objectives.
    Kurt Gielen
    Chemelot Campus B.V.
  • Great way to expand network with global experts in cell and gene therapy who are facing similar challenges.
    Steven Goodman
    GSK